No products in the cart.
Return To Shop
Need Help? Call us at: +91 9002 1002 33 (9:00 AM - 5:00 PM)
Email us: info@altuslifecares.com
Compare
Please, enable Compare.
Sale
Price range: $293.46 through $1,329.54
Have questions?
Our experts are ready to help.
Call : +91 9002 1002 33
| COUNTRY OF ORIGIN | India |
|---|---|
| DOSAGE FORM | Injection |
| GENERIC NAME | Tirzepatide Injection |
| INDICATION | To improve glycemic control in adults with Type 2 diabetes mellitus, Management of Obesity |
| PACKAGING | 1 Pre-filled Pen |
| MANUFACTURER | Eli Lilly |
| COMPOSITION | Tirzepatide (7.5mg) |
Product introduction
Mounjaro 7.5mg KwikPen improves blood sugar control in adults with type 2 diabetes when used in conjunction with a balanced diet and regular exercise. It aids in weight loss for obese (BMI ≥30) or overweight (BMI 27 and <30) adults by increasing insulin sensitivity and reducing hunger.
Mounjaro 7.5mg KwikPen is a once-weekly injection administered subcutaneously in the abdomen, thigh, or upper arm. It’s essential to rotate injection sites to prevent skin irritation and ensure the proper absorption of the medicine. Take the injection on the same day each week and at the same time, as missing doses or inconsistent use may reduce the effectiveness of the medicine.
Always follow your doctor’s instructions about the dosage, timings, use, and storage of Mounjaro 7.5mg KwikPen. Keep the medicine in a refrigerator (2°C–8°C), but do not freeze it. If left out at room temperature, consult your pharmacist to determine if it is safe to use.
Common side effects of Mounjaro 7.5mg KwikPen are nausea, diarrhea, vomiting, constipation, abdominal pain, and dyspepsia (indigestion). These symptoms are usually mild and tend to improve as your body adjusts to the medicine. However, if these symptoms continue, consult a doctor. Eating smaller meals and staying hydrated can minimize the discomfort from gastrointestinal symptoms.
Mounjaro 7.5mg KwikPen is not suitable for everyone. It must not be used by individuals who have a personal or family history of a rare thyroid cancer (medullary carcinoma) or multiple endocrine neoplasia syndrome type 2 (MEN2). This medicine may increase the risk of these tumors. Pregnant women or those planning to conceive should avoid this medication since animal studies suggest that it may cause potential risks to the unborn baby. Also, talk to your doctor if you are breastfeeding, as the developmental and health benefits of breastfeeding should be kept in mind along with the mother’s clinical needs for Mounjaro 7.5mg KwikPen.
Before starting this medicine, inform your doctor about all the medications you are currently taking to prevent possible interactions. Regularly monitor your blood sugar levels and attend regular check-ups to maintain optimal health. This helps your doctor track your progress, adjust your dosage if needed, and ensure your treatment is safe and effective. Avoid self-medicating, and always consult your doctor if you experience any unusual symptoms.
Uses of Mounjaro Solution for Injection
- To improve glycemic control in adults with Type 2 diabetes mellitus
- Management of Obesity
Benefits of Mounjaro Solution for Injection
In To improve glycemic control in adults with Type 2 diabetes mellitus
Mounjaro 7.5mg KwikPen stimulates the body’s natural insulin response when blood sugar is high. It also reduces glucagon secretion, preventing excessive glucose production simultaneously. This dual action helps lower blood sugar levels and improve long-term glucose control.
In Management of Obesity
Mounjaro 7.5mg KwikPen supports weight loss in individuals with obesity when used in conjunction with a healthy diet and regular exercise. It helps reduce appetite and calorie intake, making it easier to eat healthy and maintain a healthier lifestyle. In obese individuals, weight reduction decreases the risk of obesity-related conditions like heart disease, high blood pressure, and type 2 diabetes.
Side effects of Mounjaro Solution for Injection
Most side effects do not require any medical attention and disappear as your body adjusts to the medicine. Consult your doctor if they persist or if you’re worried about them
Common side effects of Mounjaro
- Nausea
- Vomiting
- Diarrhea
- Abdominal pain
- Indigestion
- Constipation
How to use Mounjaro Solution for Injection
Your doctor or nurse will guide you how to use this medicine.
How Mounjaro Solution for Injection works
It helps control blood sugar and support weight loss by imitating the effects of two natural hormones—GLP-1 (glucagon-like peptide-1) and GIP (glucose-dependent insulinotropic polypeptide) in your body. It helps your body release insulin when blood sugar is high and lowers the hormone that raises blood sugar. It also slows down the rate at which food leaves your stomach, so you feel full for longer and eat less. By acting on your brain to reduce hunger, this medicine helps you manage blood sugar better and lose weight more effectively than other medicines that target only one hormone.
Safety advice
Alcohol
CONSULT YOUR DOCTOR
It is not known whether it is safe to consume alcohol with Mounjaro 7.5mg KwikPen. Please consult your doctor.
Pregnancy
CONSULT YOUR DOCTOR
The safety of Mounjaro 7.5mg KwikPen during pregnancy has not been established. There are no adequate and well-controlled studies in pregnant women, and animal data on reproductive toxicity are insufficient. Your doctor will weigh the benefits and any potential risks before prescribing.
Additionally, Mounjaro 7.5mg KwikPen may reduce the effectiveness of oral hormonal contraceptives due to delayed gastric emptying. Patients using oral contraceptives should either switch to a non-oral contraceptive method or use an additional barrier method (e.g., condoms) for 4 weeks after starting Mounjaro 7.5mg KwikPen and for 4 weeks after each dose escalation.
Additionally, Mounjaro 7.5mg KwikPen may reduce the effectiveness of oral hormonal contraceptives due to delayed gastric emptying. Patients using oral contraceptives should either switch to a non-oral contraceptive method or use an additional barrier method (e.g., condoms) for 4 weeks after starting Mounjaro 7.5mg KwikPen and for 4 weeks after each dose escalation.
Breast feeding
CONSULT YOUR DOCTOR
Information regarding the use of Mounjaro 7.5mg KwikPen during breastfeeding is not available. Please consult your doctor.
They will weigh its benefits against potential risks to the infant and advise you accordingly.
They will weigh its benefits against potential risks to the infant and advise you accordingly.
Driving
CONSULT YOUR DOCTOR
It is not known whether Mounjaro 7.5mg KwikPen alters the ability to drive. Do not drive if you experience any symptoms that affect your ability to concentrate and react. Please consult your doctor.
Kidney
SAFE IF PRESCRIBED
It is safe to use in patients with kidney disease. No dose adjustment is recommended.
Liver
SAFE IF PRESCRIBED
It is safe to use in patients with liver disease. No dose adjustment is recommended.
What if you forget to take Mounjaro Solution for Injection?
If you miss a dose of Mounjaro 7.5mg KwikPen, administer it as soon as possible within four days (96 hours). If more than four days have passed, skip the missed dose and resume your regular schedule. The day of weekly administration can be changed, if necessary, as long as the time between the two doses is at least 3 days (72 hours).
| Pack Size | 1 prefilled pen, 3 prefilled pen, 5 prefilled pen |
|---|
Related products
People also bought
-
From: $352.29 -
From: $352.29 -
From: $293.46 -
From: $293.46
Mounjaro 7.5mg KwikPen From: $293.46
Reviews
There are no reviews yet.